Cost-effectiveness of using an extensively hydrolysed formula compared to an amino acid formula as first-line treatment for cow milk allergy in the UK

Pediatric Allergy and Immunology

Volumn 23, Issue 3, 2012, Pages 240-249

  Taylor, Riza R ^a   Sladkevicius, Erikas ^a   Panca, Monica ^a   Lack, Gideon ^b   Guest, Julian F ^a,c  

^a CATALYST Health Economics Consultants   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amino acid formula; Budget impact; Cost; Cost effectiveness; Cow milk allergy; EHF; Extensively hydrolysed formula; Neocate; Nutramigen; Resource use; Soy; UK

Indexed keywords

ADRENALIN; AMINO ACID; ANTACID AGENT; ANTIHISTAMINIC AGENT; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NEOCATE; PROTEIN HYDROLYSATE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MILK; BODY WEIGHT; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE REGISTRY; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; ECZEMA; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MILK ALLERGY; NATIONAL HEALTH SERVICE; PRESCHOOL CHILD; PRIORITY JOURNAL; SOYBEAN MILK; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; URTICARIA;

AMINO ACIDS; ANIMALS; CARBOHYDRATES; CATTLE; COST-BENEFIT ANALYSIS; DIETARY FATS; FEMALE; FOOD, FORMULATED; GREAT BRITAIN; HUMANS; INFANT; INFANT FOOD; INFANT FORMULA; INFANT, NEWBORN; MALE; MILK HYPERSENSITIVITY; PROTEIN HYDROLYSATES;

EID: 84859872263     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2011.01262.x     Document Type: Article

References (25)

1. Hill DJ, Firer MA, Shelton MJ, et al. Manifestations of milk allergy in infancy: clinical and immunological findings. J Pediatr 1986: 109: 270-6.
2. Action Against Allergy. Available on line at: Last accessed 19 January 2011.
3. Høst A, Halken SA. A prospective study of cow milk allergy in Danish infants during the first 3years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy 1990: 45: 587-96.
4. Bishop J, Hill DJ, Hoskings CS. Natural history of milk allergy: clinical outcome. J Pediatr 1990: 116: 862-7.
5. Hill DJ, Duke AM, Hosking CS, et al. Clinical manifestations of cow's milk allergy. The diagnostic value of skin tests and RAST. Clin Allergy 1998: 18: 481-90.
6. Walker-Smith JA. Diagnostic criteria for gastrointestinal food allergy in childhood. Clin Exp Allergy 1995: 25: 20-2.
7. Osborn DA, Sinn J. Soy formula for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2004: 3: CD003741.
8. Seppo L, Korpela R, Lonnerdal B, et al. A follow-up study of nutrient intake, nutritional status, and growth in infants with cow milk allergy fed either a soy formula or an extensively hydrolyzed whey formula. Am J Clin Nutr 2005: 82: 140-5.
9. de Boissieu D, Matarazzo P, Dupont C. Allergy to extensively hydrolyzed cow milk proteins in infants: identification and treatment with an acid-based formula. J Pediatr 1997: 131: 744-7.
10. Hill DJ, Heine RG, Cameron DJS, et al. The natural history of intolerance to soy and extensively hydrolyzed formula in infants with multiple food protein intolerance (MFPI). J Pediatr 1999: 135: 118-21.
11. Kanny G, Moneret-Vautrin DA, Flabbee J, et al. Use of an amino-acid-based formula in the treatment of cow's milk protein allergy and multiple food allergy syndrome. Allerg Immunol 2002: 34: 82-4.
12. Moneret-Vautrin DA, Hatahet R, Kanny G. Protein hydrolysates: hypoallergenic milks and extensively hydrolyzed formulas. Immuno-allergic basis for their use in prevention and treatment of milk allergy. Arch Pediatr 2001: 8: 1348-57.
13. Food Standards Agency. Survey of total and inorganic arsenic in rice drinks. Food Survey Information Sheet 02/09. Available on line at Last accessed 23 November 2011.
14. Vandenplas Y, Brueton M, Dupont C, et al. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child 2007: 92: 902-8.
15. CMO's Update 37. Department of Health January 2004. Available on line at: Last accessed 18 January 2011.
16. The Health Improvement Network (THIN) Database. London: EPIC, 2009.
17. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008: 94: 34-9.
18. Department for Health. 2010. Available on line at: Last accessed 28 October 2010.
19. Department of Health. NHS Reference Costs 2008/09. Available on line at: Last accessed 3 December 2010.
20. Curtis L. Unit Costs of Health and Social Care 2009. Canterbury: University of Kent. Personal Social Services Research Unit, 2009.
21. Drug Tariff 2009. Available on line at: Last accessed 3 August 2010.
22. Office for National statistics. Available on line at: Last accessed 3 December 2010.
23. Santos A, Dias A, Pinheiro JA. Predictive factors for the persistence of cow's milk allergy. Pediatr Allergy Immunol 2010: 21: 1127-34.
24. Terracciano L, Bouygue GR, Sarratud T, et al. Impact of dietary regimen on the duration of cow's milk allergy: a random allocation study. Clin Exp Allergy 2010: 40: 637-42.
25. Sladkevicius E, Nagy E, Lack G, Guest JF. Resource implications and budget impact of managing cow milk allergy in the UK. J Med Econ 2010: 13: 119-28.